Daxor Revenue

In the year 2023, Daxor had annual revenue of $34.59M with 448.16% growth. Revenue in the quarter ending December 31, 2023 was $36.35M, a -11,314.54% decrease year-over-year.

Revenue (ttm)

$34.67M

Revenue Growth

-18,720.02%

P/S Ratio

1.20

Revenue / Employee

$937,080

Employees

Market Cap

41.48M USD

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	34.59M	28.28M	448.16%
Dec 31, 2022	6.31M	489.11K	8.40%
Dec 31, 2021	5.82M	6.82M	-684.28%
Dec 31, 2020	-996.30K	-881.31K	766.41%
Dec 31, 2019	-114.99K	803.46K	-87.48%
Dec 31, 2018	-918.45K	93.14K	-9.21%
Dec 31, 2017	-1.01M	-2.85M	-155.12%
Dec 31, 2016	1.84M	9.28M	-124.66%
Dec 31, 2015	-7.44M	-3.39M	83.63%
Dec 31, 2014	-4.05M	7.50M	-64.93%
Dec 31, 2013	-11.56M	-9.46M	449.78%
Dec 31, 2012	-2.10M	-3.38M	-264.57%
Dec 31, 2011	1.28M	-301.84K	-19.11%
Dec 31, 2010	1.58M	-109.57K	-6.49%
Dec 31, 2009	1.69M	-72.23K	-4.10%
Dec 31, 2008	1.76M	-108.72K	-5.81%
Dec 31, 2007	1.87M	383.33K	25.79%
Dec 31, 2006	1.49M	142.91K	10.64%
Dec 31, 2005	1.34M	125.13K	10.27%
Dec 31, 2004	1.22M	-1.95M	-61.51%
Dec 31, 2003	3.17M	463.50K	17.15%
Dec 31, 2002	2.70M	1.94M	256.28%
Dec 31, 2001	758.37K	12.58K	1.69%
Dec 31, 2000	745.79K	170.41K	29.62%
Dec 31, 1999	575.38K	275.38K	91.79%
Dec 31, 1998	300.00K	-200.00K	-40.00%
Dec 31, 1997	500.00K	-2.30M	-82.14%
Dec 31, 1996	2.80M	-1.90M	-40.43%
Dec 31, 1995	4.70M	100.00K	2.17%
Dec 31, 1994	4.60M	-200.00K	-4.17%
Dec 31, 1993	4.80M	-1.30M	-21.31%
Dec 31, 1992	6.10M	2.20M	56.41%
Dec 31, 1991	3.90M	-700.00K	-15.22%
Dec 31, 1990	4.60M	2.40M	109.09%
Dec 31, 1989	2.20M	-2.20M	-50.00%
Dec 31, 1988	4.40M	2.50M	131.58%
Dec 31, 1987	1.90M	100.00K	5.56%
Dec 31, 1986	1.80M	-	-
Dec 31, 1985	1.80M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
CareCloud	113.02M
DarioHealth	19.04M
Daré Bioscience	2.82M
HCW Biologics	1.16M
Clene	620.00K

Revenue Rankings

DXR News

7 weeks ago - Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital - GlobeNewsWire
2 months ago - Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics - GlobeNewsWire
2 months ago - Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024 - GlobeNewsWire
2 months ago - Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders - GlobeNewsWire
2 months ago - Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023 - GlobeNewsWire
2 months ago - Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base - GlobeNewsWire
3 months ago - Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor's Unique Clinical Utility for Heart Failure Patients - GlobeNewsWire
3 months ago - Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference - GlobeNewsWire

More News